EichorEICHOR
Location: Toulouse Synced from ClinicalTrials.gov · August 08, 2026

Clinical studies recruiting near Toulouse

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

Study of ALXN1920 in Adult Participants With Primary Membranous Nephropathy (PMN)
Phase 2 · Research Site · Alexion Pharmaceuticals, Inc. · NCT07157787Use of a Freeze-dried Amniotic Membrane Post Crosslinking in Subjects With Progressive Keratoconus
Phase 3 · CHU de Toulouse · TBF Genie Tissulaire · NCT06450470A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Phase 3 · Oncopole Claudius Regaud · Eli Lilly and Company · NCT07218380Molecular Prediction of Development, Progression or Complications of Kidney, Immune or Transplantation-related Diseases
Phase N/A · Rangueil University Hospital · University Hospital, Toulouse · NCT05318196Glucocorticoids Versus Placebo for the Treatment of Acute Exacerbation of Idiopathic Pulmonary Fibrosis
Phase 3 · CHU Toulouse · Fondation Hôpital Saint-Joseph · NCT05674994Study of Efficacy and Safety of Iptacopan in Participants With IC-MPGN
Phase 3 · Novartis Investigative Site · Novartis Pharmaceuticals · NCT05755386A Study to Investigate Efficacy and Safety of SAR441566 in Patients With Ulcerative Colitis
Phase 2 · Investigational Site Number : 2500001 · Sanofi · NCT06867094Study of Trastuzumab Deruxtecan Versus Standard of Care Chemotherapy for HER2-Expressing (IHC 3+/2+) Endometrial Cancer
Phase 3 · Institut Claudius Regaud · Daiichi Sankyo · NCT07022483DVT Burden and the Risk of Post-thrombotic Syndrome
NA · Clinique Rive Gauche · Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer · NCT06385353Tucatinib and Trastuzumab in HER3-mutant and HER2-not Amplified Metastatic Breast Cancer
Phase 2 · Institut Universitaire du Cancer de Toulouse (IUCT) - Oncopo · Institut Curie · NCT07193394A Clinical Trial to Test the Safety, Tolerability, and How the Body Processes CPV-104 in Healthy People and Patients Wit
Phase 1 · Centre Hospitalier Universitaire De Toulouse · eleva GmbH · NCT07483827Interfant-21 Treatment Protocol for Infants Under 1 Year With KMT2A-rearranged ALL or Mixed Phenotype Acute Leukemia
Phase 3 · Centre Hospitalier Universitaire de Toulouse · Princess Maxima Center for Pediatric Oncology · NCT05327894A Clinical Study of Islatravir and Ulonivirine for People With HIV-1 Who Have Not Been Treated Before (MK-8591B-062)
Phase 2/Phase 3 · Centre Hospitalier Universitaire de Toulouse - Hôpital Purpa · Merck Sharp & Dohme LLC · NCT07266831This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in
Phase 3 · CHU de Toulouse - Hopital Larrey · Pfizer · NCT06758401Efficacy and Safety of MB-CART2019.1 vs. SoC in Lymphoma Patients
Phase 2 · Institut Universitaire du Cancer Service d´hématologie · Miltenyi Biomedicine GmbH · NCT04844866Assessment the sExual Quality of Life in Breast Cancer Patients Receiving oncoSexology Supportive Care on Proactive Vers
NA · IUCT - Oncopole · Institut du Cancer de Montpellier - Val d'Aurelle · NCT06415266A Study to Assess Safety, Tolerability and Imaging Characteristics of [68Ga]Ga-DPI-4452 and to Assess Safety, Tolerabili
Phase 1/Phase 2 · IUCT - Oncopole · Lumara Bio Oncologics GmbH · NCT05706129PulseSelect™ PFA Global Registry
Phase N/A · Clinique Pasteur · Medtronic Cardiac Ablation Solutions · NCT06393920Von Willebrand Factor Point-of-care Testing to Improve Minimally Invasive TAVI Outcomes
NA · CHU de Toulouse · University Hospital, Lille · NCT03728049Study of the Use of Non-invasive Ventilation in Bronchial Dilatation Disease
Phase N/A · Centre Hospitalier Universitaire Toulouse · Centre Hospitalier Intercommunal Creteil · NCT06987461French Colorectal ESD Cohort in Experts Centers
Phase N/A · CHU de Toulouse · University Hospital, Limoges · NCT04592003Evaluation of the Efficacy of Dd-cfDNA in Routine Patient Care in Kidney Transplant Recipients"
NA · CHU Toulouse · Assistance Publique - Hôpitaux de Paris · NCT06406179Metabolic Fluid Responsiveness in Children
Phase N/A · Hôpital des enfants - CHU de Toulouse · University Hospital, Bordeaux · NCT07255469Performance and Safety of a Digital Tool for Unsupervised Self-assessment of NMOSD
NA · CHU Toulouse - Hôpital Purpan · Ad scientiam · NCT05566769A Study of Zasocitinib in Adults With Nonsegmental Vitiligo
Phase 2 · Centre Hospitalier Universitaire (CHU) de Toulouse - Hopital · Takeda · NCT07108283A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have or Have Not Been Treated With Biologic Medicines
Phase 3 · CHU Toulouse · Takeda · NCT06671496Blockade of the Renin-angiotensin-aldosterone System in Patients With ARVD
Phase 2 · Hôpital Rangueil · Hospices Civils de Lyon · NCT03593317Study of Lymphatic Dysfunction in Primary and Secondary Lymphedema
NA · Toulouse Hospital · University Hospital, Toulouse · NCT05629026Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)
Phase 3 · CHU de Toulouse - Hôpital des Enfants · PedAL BCU, LLC · NCT05183035Home-based Cognitive Strategy Training for Daily Living in Adults With Chronic Stroke
NA · University Hospital of Toulouse · University Hospital, Toulouse · NCT07084025
Look up another city
Look up another condition
Eichor
Clinical intelligence from public evidence
Use of Eichor is governed by our Terms of Use · Privacy Policy
© 2026 Biomedistats LLC (dba Eichor)

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.